Epcs autologous transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy23

Hematopoietic Stem Cells Stem Cells Bone Marrow Cells, Cultured Bone Marrow Cells Endothelial Cells T-Lymphocytes Transplants Antilymphocyte Serum Fetal Blood Leukocytes, Mononuclear T-Lymphocytes, Cytotoxic Liver Mesenchymal Stromal Cells Endothelium, Vascular Hindlimb Blood Cells Lymphocytes Dendritic Cells Portal Vein Clone Cells Kidney CD4-Positive T-Lymphocytes

Organisms8

Transplantation Chimera Lentivirus Rabbits Mice, Inbred C57BL Rats, Inbred Lew Rats, Nude Mice, SCID Mice, Inbred BALB C

Diseases39

Multiple Myeloma Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hodgkin Disease Hematologic Neoplasms Neoplasm, Residual Lymphoma Leukemia Leukemia, Myeloid, Acute Myelodysplastic Syndromes Liver Failure Postoperative Complications Neoplasm Recurrence, Local Disease Progression Cadaver Liver Diseases Ischemia Acute Disease Kidney Failure, Chronic Disease Models, Animal Anemia, Aplastic Cytomegalovirus Infections Bronchiolitis Obliterans Blood Group Incompatibility Precursor Cell Lymphoblastic Leukemia-Lymphoma End Stage Liver Disease Infection Leukemia, Myeloid Liver Cirrhosis Hematologic Diseases Brain Death Hepatic Veno-Occlusive Disease Liver Failure, Acute Lymphoproliferative Disorders Leukemia, Myelogenous, Chronic, BCR-ABL Positive Primary Graft Dysfunction Delayed Graft Function Liver Neoplasms

Chemicals and Drugs35

Melphalan Antigens, CD34 Carmustine Granulocyte Colony-Stimulating Factor Cyclophosphamide Etoposide Busulfan Immunosuppressive Agents Cytarabine Myeloablative Agonists Thalidomide Kanamycin Kinase Vincristine Idarubicin Prednisone Antineoplastic Agents, Alkylating Dexamethasone Antigens, CD Antibodies, Monoclonal, Murine-Derived Doxorubicin Antibodies, Monoclonal Antineoplastic Agents Cyclosporine Tacrolimus HLA Antigens Recombinant Proteins Antilymphocyte Serum Thiotepa Mycophenolic Acid Antigens, Neoplasm Biological Markers ABO Blood-Group System Vidarabine Isoantibodies Isoantigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment91

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Kidney Transplantation Hematopoietic Stem Cell Mobilization Peripheral Blood Stem Cell Transplantation Treatment Outcome Combined Modality Therapy Cell Transplantation Heart Transplantation Salvage Therapy Lung Transplantation Bone Marrow Purging Leukapheresis Whole-Body Irradiation Antineoplastic Combined Chemotherapy Protocols Remission Induction Organ Transplantation Disease-Free Survival Survival Analysis Retrospective Studies Blood Transfusion, Autologous Survival Rate Pancreas Transplantation Islets of Langerhans Transplantation Transplantation Follow-Up Studies Transplantation, Isogeneic Blood Component Removal Feasibility Studies Prognosis Cell Separation Genetic Therapy Colony-Forming Units Assay Cord Blood Stem Cell Transplantation Transplantation, Heterotopic Blood Cell Count Heart-Lung Transplantation Flow Cytometry Immunomagnetic Separation Cell Culture Techniques Transduction, Genetic Immunosuppression Prospective Studies Histocompatibility Testing Skin Transplantation Fetal Tissue Transplantation Mesenchymal Stem Cell Transplantation Transplantation, Heterologous Tissue Transplantation Multivariate Analysis Corneal Transplantation Brain Tissue Transplantation Polymerase Chain Reaction Facial Transplantation Organ Preservation Donor Selection Risk Factors Lymphocyte Culture Test, Mixed Tissue and Organ Harvesting Disease Models, Animal Lymphocyte Activation Postoperative Period Cell Count Actuarial Analysis Lymphocyte Transfusion Hand Transplantation Models, Animal Patient Selection Neoplasm Transplantation Lymphocyte Depletion Cell- and Tissue-Based Therapy Bone Transplantation Immunotherapy, Adoptive Biopsy Fatal Outcome Tissue Engineering Blood Transfusion Anastomosis, Surgical Coculture Techniques Immunotherapy Cryopreservation Immunophenotyping Immunohistochemistry Kaplan-Meier Estimate Incidence Postoperative Care

Phenomena and Processes23

Graft Survival Graft Rejection Time Factors Transplantation Immunology Graft vs Tumor Effect Hematopoiesis Blood Cell Count Cell Differentiation Genetic Vectors Transduction, Genetic Transplantation Tolerance Histocompatibility Neovascularization, Physiologic Cytotoxicity, Immunologic Lymphocyte Activation Regeneration Cell Proliferation Cell Count Cell Movement Chimerism Graft vs Leukemia Effect Immune Tolerance Cell Survival

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture1

Tissue Engineering

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups2

Tissue Donors Living Donors

Health Care20

Treatment Outcome Disease-Free Survival Survival Analysis Retrospective Studies Survival Rate Follow-Up Studies Feasibility Studies Prospective Studies Tissue and Organ Procurement Multivariate Analysis Waiting Lists Donor Selection Risk Factors Postoperative Period Actuarial Analysis Patient Selection Fatal Outcome Kaplan-Meier Estimate Incidence Postoperative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Multiple Myeloma Kidney Transplantation Melphalan Hematopoietic Stem Cell Mobilization Graft Survival Peripheral Blood Stem Cell Transplantation Treatment Outcome Combined Modality Therapy Cell Transplantation Antigens, CD34 Heart Transplantation Lymphoma, Non-Hodgkin Salvage Therapy Lung Transplantation Bone Marrow Purging Carmustine Recurrence Hematopoietic Stem Cells Leukapheresis Granulocyte Colony-Stimulating Factor Graft vs Host Disease Cyclophosphamide Whole-Body Irradiation Antineoplastic Combined Chemotherapy Protocols Remission Induction Stem Cells Organ Transplantation Disease-Free Survival Survival Analysis Etoposide Busulfan Retrospective Studies Hodgkin Disease Blood Transfusion, Autologous Hematologic Neoplasms Graft Rejection Immunosuppressive Agents Survival Rate Pancreas Transplantation Time Factors Cytarabine Islets of Langerhans Transplantation Tissue Donors Transplantation Immunology Transplantation Follow-Up Studies Graft vs Tumor Effect Myeloablative Agonists Transplantation Chimera Bone Marrow Thalidomide Cells, Cultured Kanamycin Kinase Transplantation, Isogeneic Bone Marrow Cells Vincristine Blood Component Removal Feasibility Studies Prognosis Cell Separation Genetic Therapy Neoplasm, Residual Colony-Forming Units Assay Cord Blood Stem Cell Transplantation Endothelial Cells Lymphoma Hematopoiesis Living Donors Transplantation, Heterotopic Idarubicin Prednisone Blood Cell Count Heart-Lung Transplantation Leukemia Antineoplastic Agents, Alkylating Dexamethasone Leukemia, Myeloid, Acute Myelodysplastic Syndromes Flow Cytometry Immunomagnetic Separation Cell Culture Techniques Cell Differentiation Genetic Vectors Transduction, Genetic Lentivirus Immunosuppression Prospective Studies Transplantation Tolerance Antigens, CD Tissue and Organ Procurement Antibodies, Monoclonal, Murine-Derived Histocompatibility Testing Doxorubicin

No FAQ available that match "epcs autologous transplantation"